Associations between psychedelic use and migraine history in Swedish twins
Journal of Psychopharmacology · 2026-05 · 40 (5) · 831-836
DOI: 10.1177/02698811261449385 ↗Kurz gefasst
Zwillingsstudie in der Zeitschrift Journal of Psychopharmacology, online erschienen am 11.05.2026. Verfasst von Otto Simonsson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Hallucinogens, Migraine Disorders. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ekhagastiftelsen.
Abstract (Originalsprache)
Background
While psychedelics have shown initial promise in the treatment of migraine, experimental studies have relied on small and homogenous samples, which limit the reliability and generalizability of findings. These limitations underscore the complementary value of other research designs that leverage larger and more representative samples.
Methods
This cross-sectional study included three cohorts of twins from the Swedish Twin Registry and evaluated associations between psychedelic use and migraine history.
Results
In this study, 50,726 twins answered questions related to the use of psychedelics. There were 1287 twins who reported psychedelic use, of whom 420 were monozygotic twins. While 271 twin pairs were discordant on psychedelic use, 40 twin pairs (16 male, 24 female) were discordant on both psychedelic use and migraine history. When restricting the analyses to monozygotic twins in the between-within logistic regression model, the between-pair association was significant, with pairs in which at least one twin reported psychedelic use showing lower odds of migraine history (adjusted odds ratio (aOR) = 0.50, p = 0.041). The within-pair association was also significant, with twins who reported psychedelic use showing lower odds of migraine history compared to their co-twin (aOR = 0.38, p = 0.008). Notably, subgroup analyses showed that these results were broadly the same when only males were included in the models, but no significant associations were observed in female-only models.
Conclusions
The findings from this twin study suggest that psychedelics may be linked to a lower likelihood of migraine, with potential differences by sex. This warrants further investigation and highlights the importance of sex-specific analyses in future studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
- Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
- Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
- Department of Psychiatry, Amsterdam UMC, University of Amsterdam, the Netherlands.
- Department of Cognitive Neuropsychology, Max Planck Institute for Empirical Aesthetics, Frankfurt am Main, Germany.
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Otto Simonsson, Sunjuri Sun, Walter Osika
Förderung
- Ekhagastiftelsen
Zitieren
APA
Simonsson, O., Sun, S., Wesseldijk, L. W., Ullén, F., Osika, W., & Mosing, M. A. (2026). Associations between psychedelic use and migraine history in Swedish twins. Journal of Psychopharmacology, 40(5), 831-836. https://doi.org/10.1177/02698811261449385
Vancouver
Simonsson O, Sun S, Wesseldijk LW, Ullén F, Osika W, Mosing MA. Associations between psychedelic use and migraine history in Swedish twins. Journal of Psychopharmacology. 2026;40(5):831-836. doi:10.1177/02698811261449385
BibTeX
@article{Simonsson2026,
author = {Simonsson, Otto and Sun, Sunjuri and Wesseldijk, Laura W and Ullén, Fredrik and Osika, Walter and Mosing, Miriam A},
title = {Associations between psychedelic use and migraine history in Swedish twins},
journal = {Journal of Psychopharmacology},
year = {2026},
volume = {40},
number = {5},
pages = {831--836},
doi = {10.1177/02698811261449385}
}
EUVIMED